The FDA has approved certain weight loss drugs for chronic weight management in adults with obesity or overweight, with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. One such drug is Wegovy (semaglutide) injection, which is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater
. Other FDA-approved weight loss drugs include Zepbound, Mounjaro, and Ozempic, which are used for type 2 diabetes and weight loss
. However, it's important to note that many weight loss products marketed as dietary supplements may contain hidden drug ingredients, posing potential health risks. The FDA has issued public notifications about tainted weight loss products containing hidden drug ingredients, such as sibutramine, fenproporex, fluoxetine, bumetanide, furosemide, phenytoin, rimonabant, cetilistat, and phenolphthalein
. Additionally, the FDA advises caution when purchasing over-the-counter weight loss pills, as they may contain unknown or dangerous chemicals
. Therefore, it's crucial to consult healthcare professionals before using any weight loss products to ensure safety and effectiveness.
